serum CA125, CA199,Estradiol, FSH, IL-6, TNF-α in Endometriosis after administration of Tripterygium Wilfordii Glycosides: serum CA125, CA199,Estradiol, FSH, IL-6, TNF-α in Endometriosis
Scindeks Assistant Scindeks Assistant — A system for serious journals and those aspiring to become one
PDF

Abstract

Aim:To evaluate the therapeutic effects of Tripterygium wilfordii glycosides on endometriosis (EMs) and their effects on serum sex hormone levels, tumor markers, and inflammatory factors (serum CA125, CA199,Estradiol, FSH, IL-6, TNF-α).

Methods:A total of 108 patients were randomly divided into control, progesterone, and Tripterygium wilfordii glycoside-treated groups, each receiving treatment for three months. The clinical efficacy and serum levels of estradiol, follicle-stimulating hormone, tumor markers (cancer antigen125 and cancer antigen199), and pro-inflammatory cytokines were compared before and after treatment.

Results:The Tripterygium wilfordii glycoside group exhibited a significantly higher clinically effective rate (90.74% versus 75.93%) and more significant reductions in estradiol, follicle-stimulating hormone, cancer antigen125, cancer antigen199, IL-6, TNF-α, and HSCRP levels than the control group.

Conclusion: Tripterygium glycosides exhibit significant clinical efficacy in treating patients with EMs by significantly improving serum sex hormone levels, reducing tumor marker levels, alleviating inflammatory reactions, and exerting minimal toxic side effects.

Keywords

Array
DOI: 10.5937/jomb0-56632

References

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Downloads

Download data is not yet available.